期刊文献+

Efficacy of premedication with activated Dimethicone or N-acetylcysteine in improving visibility during upper endoscopy 被引量:17

Efficacy of premedication with activated Dimethicone or N-acetylcysteine in improving visibility during upper endoscopy
暂未订购
导出
摘要 AIM:To assess the efficacy of N-acetylcysteine(NAC) and activated Dimethicone in improving endoscopic mucosal visibility.METHODS:A total of 148 patients were randomly allocated into four groups to receive one of the following premedications:group A:100 mL water alone;group B:activated Dimethicone plus water(up to 100 mL);group C:NAC plus water(up to 100 mL);and group D:activated Dimethicone and NAC plus water(up to 100 mL).A single endoscopist blinded to the patients group assessed the gastric mucosal visibility scores(range 1-4) at four sites.The sum of the scores from the four sites was considered as the total mucosal visibility score(TMVS).RESULTS:The patients in group B showed a significantly lower TMVS than those of groups A and C(P < 0.001).The TMVS in patients of group D was significantly lower than that of groups A and C(P < 0.001).The TMVS did not significantly differ between groups B and D(P > 0.05).The difference between TMVS of groups C and A was not significant(P > 0.05).CONCLUSION:Premedication with activated Dimethicone 20 min prior to the upper endoscopy leads to the best visibility.NAC does not improve visualization by itself. AIM:To assess the efficacy of N-acetylcysteine(NAC) and activated Dimethicone in improving endoscopic mucosal visibility.METHODS:A total of 148 patients were randomly allocated into four groups to receive one of the following premedications:group A:100 mL water alone;group B:activated Dimethicone plus water(up to 100 mL);group C:NAC plus water(up to 100 mL);and group D:activated Dimethicone and NAC plus water(up to 100 mL).A single endoscopist blinded to the patients group assessed the gastric mucosal visibility scores(range 1-4) at four sites.The sum of the scores from the four sites was considered as the total mucosal visibility score(TMVS).RESULTS:The patients in group B showed a significantly lower TMVS than those of groups A and C(P〈0.001).The TMVS in patients of group D was significantly lower than that of groups A and C(P〈0.001).The TMVS did not significantly differ between groups B and D(P〉0.05).The difference between TMVS of groups C and A was not significant(P〉0.05).CONCLUSION:Premedication with activated Dimethicone 20 min prior to the upper endoscopy leads to the best visibility.NAC does not improve visualization by itself.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第37期4213-4217,共5页 世界胃肠病学杂志(英文版)
关键词 Dimethicone N-ACETYLCYSTEINE SIMETHICONE Upper endoscopy 二甲基硅油 高能见度 半胱氨酸 疗效观察 内窥镜术 激活 乙酰 用药
  • 相关文献

参考文献4

二级参考文献44

  • 1Savit Kositchaiwat,Weerapat Suwanthamma,Ronnarat Suvikapakornkul,Vaewvadee Tiewthanom,Prisna Rerkpatanakit,Chaowalitr Tinkornrusmee.Comparative study of two bowel preparaton regimens for colonoscopy: Senna tablets vs sodium phosphate solution[J].World Journal of Gastroenterology,2006,12(34):5536-5539. 被引量:4
  • 2You-Hong Fang,Bing-Ling Zhang,Jia-Guo Wu,Chun-Xiao Chen.A primary intestinal lymphangiectasia patient diagnosed by capsule endoscopy and confirmed at surgery: A case report[J].World Journal of Gastroenterology,2007,13(15):2263-2265. 被引量:25
  • 3[1]Moayyedi P,Ford A.Recent developments in gastroenterology.BMJ 2002; 325:1399-1402
  • 4[2]Sun J,Misumi J,Shimaoka A,Aoki K,Esaki F.Stomach cancer-related mortality.Eur J Cancer Prev 2001; 10:61-67
  • 5[3]Lambert R,Guilloux A,Oshima A,Pompe-Kirn V,Bray F,Parkin M,Ajiki W,Tsukuma H.Incidence and mortality from stomach cancer in Japan,Slovenia and the USA.Int J Cancer 2002; 97:811-818
  • 6[4]Kampschoer GH,Fujii A,Masuda Y.Gastric cancer detected by mass survey.Comparison between mass survey and outpatient detection.Scand J Gastroenterol 1989; 24:813-817
  • 7[5]Shiratori Y,Nakagawa S,Kikuchi A,Ishii M,Ueno M,Miyashita T,Sakurai T,Negami J,Suzuki T,Sato I.Significance of a gastric mass screening survey.Am J Gastroenterol 1985; 80:831-834
  • 8[6]Takemoto C,Isechi T,Matsumoto J,Kusano K,Mishige K,Nuruki F.Current status and problems of screening for gastric cancer using endoscopy.Nihon Shokaki Shudankenshin Gakkaishi 2004; 42:322-330 (in Japanese)
  • 9[7]Waye JD,Aabakken L,Armengol-Miro JR,Llorens P,Williams CB,Zhang QL.Screening for GI cancer and payment mechanisms.Gastrointest Endosc 2002; 55:453-454
  • 10[8]Whiting JL,Sigurdsson A,Rowlands DC,Hallissey MT,Field ing JW.The long term results of endoscopic surveillance of premalignant gastric lesions.Gut 2002; 50:378-381

共引文献86

同被引文献105

引证文献17

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部